z-logo
Premium
Molecular genetic studies in muscle phosphoglycerate mutase (PGAM‐M) deficiency
Author(s) -
Tsujino Seiichi,
Shanske Sara,
Sakoda Saburo,
Toscano Antonio,
DiMauro Salvatore
Publication year - 1995
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.880181412
Subject(s) - phosphoglycerate mutase , missense mutation , nonsense mutation , genetics , mutation , compound heterozygosity , nonsense , myoglobinuria , heterozygote advantage , biology , genotype , myopathy , gene , biochemistry , glycolysis , medicine , enzyme , rhabdomyolysis
Phosphoglycerate mutase (PGAM; EC 2.7.5.3) catalyzes the interconversion of 2‐phosphoglycerate and 3‐phosphoglycerate in the glycolytic pathway. Hereditary muscle PGAM deficiency has been identified in 9 patients with myopathy. All patients had exercise introlerance and 6 had myoglobinuria. Seven of the 9 patients were African‐Americans: 5 of them were homozygous for a nonsense mutation, TGG(Trp) to TAG at codon 78; 1 was a compound heterozygote for the nonsense mutation and a missense mutation, GAG(Glu) to GCG(Ala) at codon 89; and 1 could not be tested. The only 2 Caucasian patients, a brother and sister, were homozygous for a different missense mutation, CGG(Arg) to TGG(Trp) at codon 90. Despite the small number of patients identified, these findings indicate that there is a common mutation in African‐Americans while there may be molecular genetic heterogeneity in other ethnic groups. © 1995 John Wiley & Sons, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom